Abhimanyu Singh Pokhriyal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Abhimanyu Singh Pokhriyal has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Ruchira Nautiyal
Dept. of Obstetrics & Gynaecology, Swami Rama Himalayan University, Dehradun, Uttarakhand, India
2 shared publications - Amit Kumar Chauhan
Himalayan Institute of Medical Sciences, Dehradun, Uttarakhand, India
1 shared publication - Deepti Mehta
Himalayan Institute of Medical Sciences, Dehradun, Uttarakhand, India
1 shared publication Gurjeet Khurana
Department of Anaesthesiology and Pain Management, Himalayan Institute of Medical Sciences, Dehradun, Uttarakhand, India
1 shared publication- Gurjeet Khurana
Himalayan Institute of Medical Sciences, Dehradun, Uttarakhand, India
1 shared publication Jagdish P Sharma
Department of Anaesthesiology and Pain Management, Himalayan Institute of Medical Sciences, Dehradun, Uttarakhand, India
1 shared publication
Latest Publications
- Open Access
- 22 October 2026
- Published by IP Innovative Publication Pvt Ltd in Indian Journal of Clinical Anaesthesia
- Vol. 13 (4) , 660-665
Transdermal fentanyl versus buprenorphine patches for postoperative pain control after radical hysterectomy: A prospective randomized comparative trial
Background : Radical hysterectomy is associated with significant tissue trauma and postoperative pain. Conventional IV opioids and epidurals have inherent limitations. Transdermal patches offer a stable plasma concentration and an improved safety profile for managing subacute postoperative pain, facilitating early mobilisation without the physical restrictions of epidural catheters or IV PCA pumps, which is particularly beneficial for Enhanced Recovery after Surgery (ERAS) pathways in gynaecologic oncology. This study aimed to compare the analgesic efficacy and safety of transdermal fentanyl and buprenorphine patches in patients undergoing radical hysterectomy. Materials and Methods : In this prospective, randomized, double-blind trial, 100 American Society of Anesthesiologists physical status I-II patients aged 35-65 years were allocated into two groups (n = 50 each). Group F received fentanyl 25 µg/hr and Group B received buprenorphine 10 µg/hr. Patches were applied 12-16 hours preoperatively. Postoperative pain was assessed using Numerical Rating Scale for 72 hours. The primary outcome was static and dynamic pain scores measured at predefined time points from extubation to 72 hours postoperatively. Secondary outcomes included rescue analgesia (diclofenac sodium/tramadol hydrochloride), time to first request, and adverse effects (postoperative nausea and vomiting, pruritus). Results : Group B showed significantly lower Numerical Rating Scale at extubation and at 1, 2, and 72 hours (p < 0.05). The mean time to first rescue analgesic request was significantly longer in Group B (48.80 ± 21.46 hours) than in Group F (14.56 ± 12.66 hours; p = 0.001). Total diclofenac sodium consumption was significantly lower in Group B (444.0 ± 20.6 mg) vs. Group F (471.0 ± 34.0 mg; p = 0.001). Incidences of nausea/vomiting were lower in Group B (4%) compared to Group F (16%), though not statistically significant (p = 0.092). Conclusion : Transdermal buprenorphine (10 µg/hr) provides superior analgesia, longer duration of action, and higher opioid-sparing effects compared to fentanyl (25 g/hr) for radical hysterectomy.
- 22 October 2026
- Published by IP Innovative Publication Pvt Ltd in Indian Journal of Clinical Anaesthesia
- Vol. 13 (4) , 660-665
Open AccessTransdermal fentanyl versus buprenorphine patches for postoperative pain control after radical hysterectomy: A prospective randomized comparative trial
Background : Radical hysterectomy is associated with significant tissue trauma and postoperative pain. Conventional IV opioids and epidurals have inherent limitations. Transdermal patches offer a stable plasma concentration and an improved safety profile for managing subacute postoperative pain, facilitating early mobilisation without the physical restrictions of epidural catheters or IV PCA pumps, which is particularly beneficial for Enhanced Recovery after Surgery (ERAS) pathways in gynaecologic oncology. This study aimed to compare the analgesic efficacy and safety of transdermal fentanyl and buprenorphine patches in patients undergoing radical hysterectomy. Materials and Methods : In this prospective, randomized, double-blind trial, 100 American Society of Anesthesiologists physical status I-II patients aged 35-65 years were allocated into two groups (n = 50 each). Group F received fentanyl 25 µg/hr and Group B received buprenorphine 10 µg/hr. Patches were applied 12-16 hours preoperatively. Postoperative pain was assessed using Numerical Rating Scale for 72 hours. The primary outcome was static and dynamic pain scores measured at predefined time points from extubation to 72 hours postoperatively. Secondary outcomes included rescue analgesia (diclofenac sodium/tramadol hydrochloride), time to first request, and adverse effects (postoperative nausea and vomiting, pruritus). Results : Group B showed significantly lower Numerical Rating Scale at extubation and at 1, 2, and 72 hours (p < 0.05). The mean time to first rescue analgesic request was significantly longer in Group B (48.80 ± 21.46 hours) than in Group F (14.56 ± 12.66 hours; p = 0.001). Total diclofenac sodium consumption was significantly lower in Group B (444.0 ± 20.6 mg) vs. Group F (471.0 ± 34.0 mg; p = 0.001). Incidences of nausea/vomiting were lower in Group B (4%) compared to Group F (16%), though not statistically significant (p = 0.092). Conclusion : Transdermal buprenorphine (10 µg/hr) provides superior analgesia, longer duration of action, and higher opioid-sparing effects compared to fentanyl (25 g/hr) for radical hysterectomy.
- Open Access
- 15 August 2024
- Published by IP Innovative Publication Pvt Ltd in Indian Journal of Clinical Anaesthesia
- Vol. 11 (3) , 295-301
Ultrasound-guided subcostal transversus abdominis plane block versus erector spinae plane block for post-operative pain after percutaneous nephrolithotomy: A comparative observational study
In India, about 12% of the population has kidney stones, and out of these about 50% may end up with some kidney function loss or renal damage percutaneous nephrolithotomy (PCNL) is accepted as the procedure of choice for large or complex renal stones. Significant post-operative pain can occur after PCNL in first 24 hours due to distension in the renal capsule and pelvicalyceal system. The study aim was to compare the efficacy of ultrasonography guided subcostal transversus abdominis plane block with erector spinae plane block in PCNL. This observational study included 67 consecutive cases (16-65 years, ASA grade I-II) divided into 2 groups. Group A (n=33) received subcostal transversus abdominis plane (SCTAP) block and Group B (n=34) received erector spinae plane block (ESPB). Post operative pain in terms of pain scores, opioid consumption, requirement of rescue analgesic in first 24 hours was noted. Quality of recovery and any adverse events were also noted. Post-operative opioid consumption was significantly less in ESPB group (34.41 ± 27.32 mcg), compared to SCTAP Group (270.91 ± 121.41 mcg). Group B patients had better post operative quality of recovery compared to Group A patients. VAS pain scores at almost all time-points were lower in the ESPB group. ESPB provided effective postoperative analgesia and reduced fentanyl consumption postoperatively compared to SCTAP block.
- 15 August 2024
- Published by IP Innovative Publication Pvt Ltd in Indian Journal of Clinical Anaesthesia
- Vol. 11 (3) , 295-301
Open AccessUltrasound-guided subcostal transversus abdominis plane block versus erector spinae plane block for post-operative pain after percutaneous nephrolithotomy: A comparative observational study
In India, about 12% of the population has kidney stones, and out of these about 50% may end up with some kidney function loss or renal damage percutaneous nephrolithotomy (PCNL) is accepted as the procedure of choice for large or complex renal stones. Significant post-operative pain can occur after PCNL in first 24 hours due to distension in the renal capsule and pelvicalyceal system. The study aim was to compare the efficacy of ultrasonography guided subcostal transversus abdominis plane block with erector spinae plane block in PCNL. This observational study included 67 consecutive cases (16-65 years, ASA grade I-II) divided into 2 groups. Group A (n=33) received subcostal transversus abdominis plane (SCTAP) block and Group B (n=34) received erector spinae plane block (ESPB). Post operative pain in terms of pain scores, opioid consumption, requirement of rescue analgesic in first 24 hours was noted. Quality of recovery and any adverse events were also noted. Post-operative opioid consumption was significantly less in ESPB group (34.41 ± 27.32 mcg), compared to SCTAP Group (270.91 ± 121.41 mcg). Group B patients had better post operative quality of recovery compared to Group A patients. VAS pain scores at almost all time-points were lower in the ESPB group. ESPB provided effective postoperative analgesia and reduced fentanyl consumption postoperatively compared to SCTAP block.
- Open Access
- 15 August 2024
- Published by IP Innovative Publication Pvt Ltd in Indian Journal of Clinical Anaesthesia
- Vol. 11 (3) , 274-283
To study the relation of volume of local anaesthetic and diaphragmatic motility in ultrasound guided supraclavicular brachial plexus block
Supraclavicular brachial plexus block is a valuable technique for upper limb surgeries, but it carries the risk of hemi diaphragmatic paresis due to phrenic nerve involvement, which can limit its utility. Thirty-six patients undergoing forearm and hand surgery received ultrasound-guided supraclavicular brachial plexus blocks with varying volumes of 0.5% ropivacaine, determined by Dixon and Massey's up-and-down approach starting at 25 ml. We assessed diaphragmatic paralysis/paresis incidence and spirometry parameters across different volumes to optimize clinical outcomes. Among the patients, 15 ml of 0.5% ropivacaine consistently provided effective surgical anesthesia without causing diaphragmatic paralysis or paresis. The study showed no significant changes in spirometry parameters such as FEV1 and FVC with lower volumes, while higher volumes correlated with increased diaphragmatic impairment. Reducing the volume of 0.5% ropivacaine mitigates the risk of diaphragmatic paralysis associated with supraclavicular brachial plexus blocks, ensuring safe and effective anesthesia for upper limb surgeries.
- 15 August 2024
- Published by IP Innovative Publication Pvt Ltd in Indian Journal of Clinical Anaesthesia
- Vol. 11 (3) , 274-283
Open AccessTo study the relation of volume of local anaesthetic and diaphragmatic motility in ultrasound guided supraclavicular brachial plexus block
Supraclavicular brachial plexus block is a valuable technique for upper limb surgeries, but it carries the risk of hemi diaphragmatic paresis due to phrenic nerve involvement, which can limit its utility. Thirty-six patients undergoing forearm and hand surgery received ultrasound-guided supraclavicular brachial plexus blocks with varying volumes of 0.5% ropivacaine, determined by Dixon and Massey's up-and-down approach starting at 25 ml. We assessed diaphragmatic paralysis/paresis incidence and spirometry parameters across different volumes to optimize clinical outcomes. Among the patients, 15 ml of 0.5% ropivacaine consistently provided effective surgical anesthesia without causing diaphragmatic paralysis or paresis. The study showed no significant changes in spirometry parameters such as FEV1 and FVC with lower volumes, while higher volumes correlated with increased diaphragmatic impairment. Reducing the volume of 0.5% ropivacaine mitigates the risk of diaphragmatic paralysis associated with supraclavicular brachial plexus blocks, ensuring safe and effective anesthesia for upper limb surgeries.
- Open Access
- 10 December 2023
- Published by Brieflands in Anesthesiology and Pain Medicine
- Vol. 13 (6) , e142059
Dexmedetomidine vs Dexamethasone as an Adjuvant to Levobupivacaine in Ultrasound-Guided Transversus Abdominis Plane Block for Postoperative Analgesia in Patients Undergoing Total Abdominal Hysterectomies
Background: In the postoperative period, open total abdominal hysterectomy (TAH) surgeries induce considerable pain. Multimodal strategies are being used to alleviate pain. Objectives: This study aimed to examine the efficacy and safety of dexamethasone and dexmedetomidine as an adjuvant to levobupivacaine in ultrasound-guided transversus abdominis plane (TAP) blocks for postoperative pain in TAH patients. Methods: A total of 72 patients with ASA grade I and grade II were randomly and equally assigned to two groups. After the completion of surgery with a subarachnoid block (SAB), patients in group 1 received a mixture of 20 mL of 0.25% levobupivacaine and 4 mg of dexamethasone on each side of the TAP block. Patients in group 2 received a mixture of 20 mL of 0.25% levobupivacaine and dexmedetomidine, with a total dose of 1 µg/kg body weight evenly distributed bilaterally in the TAP block. Patients were evaluated for pain using the Visual Analog Scale (VAS), total tramadol consumption as rescue analgesia, time to first rescue analgesia, any adverse effects, and patient satisfaction. Results: When comparing VAS scores for pain assessment, we observed that the mean VAS score was initially comparable between the two groups for the first hour. However, at 6, 9, and 12 h, VAS scores were significantly lower in group 2. The mean total tramadol consumption was higher in group 1 than in group 2 (213.33 ± 44.08 vs 161.11 ± 37.93 mg, P-value 0.027). The time to the first rescue analgesia after the TAP block in the postoperative period was significantly longer in group 2 (47.5 ± 62.76 vs 77.22 ± 56.14 min, P-value 0.002). No significant side effects were noted, and a greater proportion of patients in group 2 expressed satisfaction with their overall pain treatment. Conclusions: The addition of dexmedetomidine to levobupivacaine is superior to the addition of dexamethasone, as it prolongs the duration of the block in the dexmedetomidine group. However, the use of dexamethasone as an adjuvant is a good alternative option, particularly due to its lower cost and reduced incidence of adverse effects such as postoperative nausea and vomiting.
- 10 December 2023
- Published by Brieflands in Anesthesiology and Pain Medicine
- Vol. 13 (6) , e142059
Open AccessDexmedetomidine vs Dexamethasone as an Adjuvant to Levobupivacaine in Ultrasound-Guided Transversus Abdominis Plane Block for Postoperative Analgesia in Patients Undergoing Total Abdominal Hysterectomies
Background: In the postoperative period, open total abdominal hysterectomy (TAH) surgeries induce considerable pain. Multimodal strategies are being used to alleviate pain. Objectives: This study aimed to examine the efficacy and safety of dexamethasone and dexmedetomidine as an adjuvant to levobupivacaine in ultrasound-guided transversus abdominis plane (TAP) blocks for postoperative pain in TAH patients. Methods: A total of 72 patients with ASA grade I and grade II were randomly and equally assigned to two groups. After the completion of surgery with a subarachnoid block (SAB), patients in group 1 received a mixture of 20 mL of 0.25% levobupivacaine and 4 mg of dexamethasone on each side of the TAP block. Patients in group 2 received a mixture of 20 mL of 0.25% levobupivacaine and dexmedetomidine, with a total dose of 1 µg/kg body weight evenly distributed bilaterally in the TAP block. Patients were evaluated for pain using the Visual Analog Scale (VAS), total tramadol consumption as rescue analgesia, time to first rescue analgesia, any adverse effects, and patient satisfaction. Results: When comparing VAS scores for pain assessment, we observed that the mean VAS score was initially comparable between the two groups for the first hour. However, at 6, 9, and 12 h, VAS scores were significantly lower in group 2. The mean total tramadol consumption was higher in group 1 than in group 2 (213.33 ± 44.08 vs 161.11 ± 37.93 mg, P-value 0.027). The time to the first rescue analgesia after the TAP block in the postoperative period was significantly longer in group 2 (47.5 ± 62.76 vs 77.22 ± 56.14 min, P-value 0.002). No significant side effects were noted, and a greater proportion of patients in group 2 expressed satisfaction with their overall pain treatment. Conclusions: The addition of dexmedetomidine to levobupivacaine is superior to the addition of dexamethasone, as it prolongs the duration of the block in the dexmedetomidine group. However, the use of dexamethasone as an adjuvant is a good alternative option, particularly due to its lower cost and reduced incidence of adverse effects such as postoperative nausea and vomiting.
- Open Access
- 1 January 2020
- Published by Medknow in Anesthesia: Essays and Researches
- Vol. 14 (1) , 42-48
Evaluation of gastric emptying by ultrasonography after recommended fasting period and administration of prokinetic in end-stage renal disease patients
Background: Delayed gastric emptying is observed in end-stage renal disease (ESRD). Aims: Evaluation of gastric emptying after recommended fasting period and on oral administration of prokinetic in ESRD patients using ultrasonography (USG). Settings and Design: Randomized, double-blind, prospective, controlled study. Materials and Methods: After institutional ethics committee approval, 200 patients were divided randomly into two equal groups. Three sessions of USG evaluation of gastric antrum were done in supine and right lateral position for assessing gastric emptying, first at 8 am, second after the light meal at 8.30 am, and third after 6 h of light meal. Group A received placebo (sugar-coated pill) and Group B received tablet metoclopramide hydrochloride 10 mg after second session of USG. In each session, measurement of anteroposterior and craniocaudal diameters of gastric antrum was done, and then cross-sectional area was estimated. Three-point grading system (Perlas) was used to perform qualitative evaluation. Statistical Analysis: Comparison of normally distributed continuous variables was performed using Student's t-test. Nominal categorical data were compared using Chi-squared test. Nonnormal distribution continuous variables were compared using Mann–Whitney U-test. Results: 6 h of fasting after light meal showed that Group A only had 14% incidence of complete gastric emptying, whereas Group B had 71% as compared by Perlas grading. Gastric antral cross-sectional area measured both in supine (480.89 ± 84.92) and right lateral (575.40 ± 92.62) position of Group A was more than Group B supine (394.15 ± 62.80) and right lateral (470.25 ± 73.63) position (P < 0.05). Conclusion: USG of ESRD patients preoperatively can evaluate gastric contents to assess risk of pulmonary aspiration and guide anesthetic management. Metoclopramide is a good drug to enhance gastric emptying in ESRD patients within the recommended fasting period.
- 1 January 2020
- Published by Medknow in Anesthesia: Essays and Researches
- Vol. 14 (1) , 42-48
Open AccessEvaluation of gastric emptying by ultrasonography after recommended fasting period and administration of prokinetic in end-stage renal disease patients
Background: Delayed gastric emptying is observed in end-stage renal disease (ESRD). Aims: Evaluation of gastric emptying after recommended fasting period and on oral administration of prokinetic in ESRD patients using ultrasonography (USG). Settings and Design: Randomized, double-blind, prospective, controlled study. Materials and Methods: After institutional ethics committee approval, 200 patients were divided randomly into two equal groups. Three sessions of USG evaluation of gastric antrum were done in supine and right lateral position for assessing gastric emptying, first at 8 am, second after the light meal at 8.30 am, and third after 6 h of light meal. Group A received placebo (sugar-coated pill) and Group B received tablet metoclopramide hydrochloride 10 mg after second session of USG. In each session, measurement of anteroposterior and craniocaudal diameters of gastric antrum was done, and then cross-sectional area was estimated. Three-point grading system (Perlas) was used to perform qualitative evaluation. Statistical Analysis: Comparison of normally distributed continuous variables was performed using Student's t-test. Nominal categorical data were compared using Chi-squared test. Nonnormal distribution continuous variables were compared using Mann–Whitney U-test. Results: 6 h of fasting after light meal showed that Group A only had 14% incidence of complete gastric emptying, whereas Group B had 71% as compared by Perlas grading. Gastric antral cross-sectional area measured both in supine (480.89 ± 84.92) and right lateral (575.40 ± 92.62) position of Group A was more than Group B supine (394.15 ± 62.80) and right lateral (470.25 ± 73.63) position (P < 0.05). Conclusion: USG of ESRD patients preoperatively can evaluate gastric contents to assess risk of pulmonary aspiration and guide anesthetic management. Metoclopramide is a good drug to enhance gastric emptying in ESRD patients within the recommended fasting period.
- Open Access
- 1 January 2019
- Published by Medknow in Anesthesia: Essays and Researches
- Vol. 13 (1) , 119-125
Effect of fentanyl and nalbuphine for prevention of etomidate-induced myoclonus
Background: Etomidate is a potent intravenous inducing agent with known undesirable side effects such as myoclonus and pain on injection in nonpremedicated patients. Aims: The aim of this study is to compare the effect of fentanyl and nalbuphine in the prevention of etomidate-induced myoclonus. Settings and Design: Randomized double-blind, placebo-controlled, and prospective comparative study. Materials and Methods: A total of 120 patients were randomly allocated to one of the three groups containing 40 patients each for intravenous administration of fentanyl 2 μg/kg diluted in 10 mL normal saline (NS) (Group 1), nalbuphine 0.3 mg/kg diluted in 10 mL NS (Group 2), and only 10 mL NS (Group 3) over 10 min. All groups subsequently received 0.3 mg/kg etomidate by intravenous bolus injection over 15–20 s and were assessed for the severity of pain using Grade IV pain scale and observed for myoclonus for 2 min and graded according to clinical severity. Serum creatinine phosphokinase (CPK) levels were obtained prior and postetomidate injection. Statistical Analysis: Statistical analysis was performed by the SPSS program version 17.0 for Windows. Tests used are Shaipro–Wilk test, ANOVA, Tukey's multiple comparison test, Tamhane's T2, and the Chi-square test. For all statistical tests,P < 0.05 was considered statistically significant with 5% level of significance (α). Results: The incidence of myoclonus in Group 1 and 2 was 52.5% and 17.5%, respectively, whereas it was 92.45% in Group 3. There was no pain observed in 70%, 92.5%, and 50% of patients in Group 1, 2, and 3, respectively. There was a statistically significant difference in mean CPK level after induction among three groups (P < 0.001). Conclusion: Nalbuphine is more effective than fentanyl in the prevention of etomidate-induced myoclonus and pain with the minimum rise in CPK levels.
- 1 January 2019
- Published by Medknow in Anesthesia: Essays and Researches
- Vol. 13 (1) , 119-125
Open AccessEffect of fentanyl and nalbuphine for prevention of etomidate-induced myoclonus
Background: Etomidate is a potent intravenous inducing agent with known undesirable side effects such as myoclonus and pain on injection in nonpremedicated patients. Aims: The aim of this study is to compare the effect of fentanyl and nalbuphine in the prevention of etomidate-induced myoclonus. Settings and Design: Randomized double-blind, placebo-controlled, and prospective comparative study. Materials and Methods: A total of 120 patients were randomly allocated to one of the three groups containing 40 patients each for intravenous administration of fentanyl 2 μg/kg diluted in 10 mL normal saline (NS) (Group 1), nalbuphine 0.3 mg/kg diluted in 10 mL NS (Group 2), and only 10 mL NS (Group 3) over 10 min. All groups subsequently received 0.3 mg/kg etomidate by intravenous bolus injection over 15–20 s and were assessed for the severity of pain using Grade IV pain scale and observed for myoclonus for 2 min and graded according to clinical severity. Serum creatinine phosphokinase (CPK) levels were obtained prior and postetomidate injection. Statistical Analysis: Statistical analysis was performed by the SPSS program version 17.0 for Windows. Tests used are Shaipro–Wilk test, ANOVA, Tukey's multiple comparison test, Tamhane's T2, and the Chi-square test. For all statistical tests,P < 0.05 was considered statistically significant with 5% level of significance (α). Results: The incidence of myoclonus in Group 1 and 2 was 52.5% and 17.5%, respectively, whereas it was 92.45% in Group 3. There was no pain observed in 70%, 92.5%, and 50% of patients in Group 1, 2, and 3, respectively. There was a statistically significant difference in mean CPK level after induction among three groups (P < 0.001). Conclusion: Nalbuphine is more effective than fentanyl in the prevention of etomidate-induced myoclonus and pain with the minimum rise in CPK levels.